SLC22A9: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
 
Line 1: Line 1:
'''SLC22A9''' is a gene that encodes a protein in the human body. This protein is part of the solute carrier family 22, member 9 (organic anion transporter), also known as [[SLC22A9]]. The SLC22A9 gene is located on chromosome 11 in humans.
{{Infobox gene
| name = SLC22A9
| symbol = SLC22A9
| HGNCid = 10965
| chromosome = 11
| arm = q
| band = 13.1
}}
 
'''SLC22A9''' is a gene that encodes a member of the [[solute carrier family 22]] (SLC22), which is involved in the transport of organic ions across cell membranes. This family of transporters plays a crucial role in the [[pharmacokinetics]] of drugs and the [[excretion]] of endogenous compounds.


== Function ==
== Function ==
The SLC22A9 gene is responsible for encoding a protein that is part of the solute carrier family. This family of proteins is involved in the transport of various substances across the cell membrane. Specifically, the protein encoded by the SLC22A9 gene is an organic anion transporter, which means it helps move negatively charged molecules, or anions, across the cell membrane.
The SLC22A9 gene product is an organic anion transporter, which is primarily expressed in the [[liver]] and [[kidney]]. It is responsible for the uptake and excretion of a wide range of organic anions, including [[drugs]], [[metabolites]], and [[toxins]]. This transporter is important for the [[detoxification]] processes in the body and influences the [[bioavailability]] and [[clearance]] of various pharmacological agents.


== Clinical Significance ==
== Clinical Significance ==
Mutations in the SLC22A9 gene can lead to various health conditions. For example, some studies have suggested a link between variations in this gene and susceptibility to [[gout]], a type of inflammatory arthritis. However, more research is needed to fully understand the role of SLC22A9 in human health and disease.
Mutations or variations in the SLC22A9 gene can affect drug response and toxicity. Understanding the function and regulation of this transporter can aid in the development of personalized medicine approaches, particularly in optimizing drug dosing and minimizing adverse drug reactions. Research into SLC22A9 may also provide insights into [[disease]] mechanisms where altered transport of organic anions is implicated.


== Research ==
== Research ==
Research into the SLC22A9 gene and its encoded protein is ongoing. Scientists are particularly interested in understanding how variations in this gene may contribute to disease susceptibility and drug response. This research could potentially lead to new treatments for diseases such as gout and other conditions related to organic anion transport.
Studies on SLC22A9 involve investigating its substrate specificity, regulatory mechanisms, and its role in [[drug-drug interactions]]. Researchers use various [[biochemical]] and [[molecular biology]] techniques to elucidate the structure-function relationship of this transporter.
 
[[File:SLC22A9 gene location on human chromosome 11.png|thumb|right|SLC22A9 gene location on human chromosome 11]]


== See Also ==
== See Also ==
* [[Solute carrier family]]
* [[Solute carrier family]]
* [[Organic anion transporter]]
* [[Organic anion transporter]]
* [[Gout]]
* [[Pharmacogenomics]]


== References ==
== References ==
<references />
<references/>
 
== External Links ==
* [https://www.ncbi.nlm.nih.gov/gene/ SLC22A9 Gene - NCBI]
* [https://www.genecards.org/cgi-bin/carddisp.pl?gene=SLC22A9 SLC22A9 Gene - GeneCards]


[[Category:Genes]]
{{Transporter-stub}}
[[Category:Human proteins]]
[[Category:Membrane transport proteins]]
[[Category:Medicine]]


{{medicine-stub}}
[[Category:Solute carrier family]]
[[Category:Genes on human chromosome 11]]
[[Category:Transport proteins]]
[[Category:Pharmacogenomics]]

Latest revision as of 20:22, 30 December 2024

SLC22A9
Symbol SLC22A9
HGNC ID 10965
Alternative symbols
Entrez Gene
OMIM
RefSeq
UniProt
Chromosome 11q13.1
Locus supplementary data


SLC22A9 is a gene that encodes a member of the solute carrier family 22 (SLC22), which is involved in the transport of organic ions across cell membranes. This family of transporters plays a crucial role in the pharmacokinetics of drugs and the excretion of endogenous compounds.

Function[edit]

The SLC22A9 gene product is an organic anion transporter, which is primarily expressed in the liver and kidney. It is responsible for the uptake and excretion of a wide range of organic anions, including drugs, metabolites, and toxins. This transporter is important for the detoxification processes in the body and influences the bioavailability and clearance of various pharmacological agents.

Clinical Significance[edit]

Mutations or variations in the SLC22A9 gene can affect drug response and toxicity. Understanding the function and regulation of this transporter can aid in the development of personalized medicine approaches, particularly in optimizing drug dosing and minimizing adverse drug reactions. Research into SLC22A9 may also provide insights into disease mechanisms where altered transport of organic anions is implicated.

Research[edit]

Studies on SLC22A9 involve investigating its substrate specificity, regulatory mechanisms, and its role in drug-drug interactions. Researchers use various biochemical and molecular biology techniques to elucidate the structure-function relationship of this transporter.

See Also[edit]

References[edit]

<references/>

External Links[edit]

Template:Transporter-stub